IE45282L - Pharmaceutical tablet formulation - Google Patents

Pharmaceutical tablet formulation

Info

Publication number
IE45282L
IE45282L IE771038A IE103877A IE45282L IE 45282 L IE45282 L IE 45282L IE 771038 A IE771038 A IE 771038A IE 103877 A IE103877 A IE 103877A IE 45282 L IE45282 L IE 45282L
Authority
IE
Ireland
Prior art keywords
tablet formulation
pharmaceutical tablet
naphtho
pyran
tetrahydro
Prior art date
Application number
IE771038A
Other versions
IE45282B1 (en
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Priority to IE2005/80A priority Critical patent/IE45283B1/en
Publication of IE45282L publication Critical patent/IE45282L/en
Publication of IE45282B1 publication Critical patent/IE45282B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

There is described a pharmaceutical tablet formulation comprising an anti-allergic drug having sodium cromoglycate like activity, as active ingredient, in combination with a lubricant and a diluent (and preferably also a flow aid and a binder) the low aid, binder, lubricant and diluent containing no material capable of causing an adverse reaction in an allergic patient. Unit dosage forms of 6,7,8,9-tetrahydro-4-oxo-10-propyl-4H-naphtho¢2,3-b!pyran-2-carboxylic acid and 6,7,8,9-tetrahydro-S-hydroxy-4-oxo-10-propyl-4H-naphtho¢2,3-b!pyran-2-ccarboxylic acid are also described. The formulations and unit dosage forms are indicated for use in the treatment of allergies. [CA1105835A]
IE1038/77A 1976-05-21 1977-05-20 Pharmaceutical tablet formulation IE45282B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE2005/80A IE45283B1 (en) 1976-05-21 1977-05-20 Pharmaceutical formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB20984/76A GB1570993A (en) 1976-05-21 1976-05-21 Pharmaceutical tablet formulation

Publications (2)

Publication Number Publication Date
IE45282L true IE45282L (en) 1977-11-21
IE45282B1 IE45282B1 (en) 1982-07-28

Family

ID=10155196

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1038/77A IE45282B1 (en) 1976-05-21 1977-05-20 Pharmaceutical tablet formulation

Country Status (17)

Country Link
JP (1) JPS52143220A (en)
AU (1) AU511269B2 (en)
BE (1) BE854690A (en)
CA (1) CA1105835A (en)
DE (1) DE2722917A1 (en)
DK (1) DK218777A (en)
FI (1) FI771587A (en)
FR (1) FR2426460A1 (en)
GB (1) GB1570993A (en)
IE (1) IE45282B1 (en)
IL (1) IL52102A0 (en)
LU (1) LU77369A1 (en)
NL (1) NL7705560A (en)
NO (1) NO771765L (en)
NZ (1) NZ184141A (en)
SE (1) SE7705850L (en)
ZA (1) ZA772989B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1595220A (en) * 1977-12-23 1981-08-12 Fisons Ltd Tablets containing 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane
US5447728A (en) * 1992-06-15 1995-09-05 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
ATE367152T1 (en) 2001-05-01 2007-08-15 Pfizer Prod Inc PRODUCTION METHOD FOR LOW DOSE PHARMACEUTICAL COMPOSITION

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA753210B (en) * 1974-06-14 1976-04-28 Upjohn Co Novel dosing regimen for intal biologues
IL48360A (en) * 1974-11-09 1978-12-17 Fisons Ltd Pharmaceutical compositions for the treatment of aphthous stomatitis comprising 1,3-bis-(2-carboxychromon-5-yloxy)-2-carboxychromon-5-yloxy)-2-hydroxypropane
FR2292468A1 (en) * 1974-11-30 1976-06-25 Fisons Ltd MONOCHROMES

Also Published As

Publication number Publication date
DE2722917A1 (en) 1977-12-01
NO771765L (en) 1977-11-22
SE7705850L (en) 1977-11-22
AU511269B2 (en) 1980-08-07
NL7705560A (en) 1977-11-23
LU77369A1 (en) 1977-12-13
IE45282B1 (en) 1982-07-28
DK218777A (en) 1977-11-22
FR2426460A1 (en) 1979-12-21
BE854690A (en) 1977-11-16
FR2426460B1 (en) 1983-04-29
NZ184141A (en) 1979-06-19
JPS52143220A (en) 1977-11-29
AU2521477A (en) 1978-11-23
CA1105835A (en) 1981-07-28
GB1570993A (en) 1980-07-09
FI771587A (en) 1977-11-22
IL52102A0 (en) 1977-07-31
ZA772989B (en) 1978-04-26

Similar Documents

Publication Publication Date Title
IE790756L (en) Cerebral therapeutic agent
ES8105292A1 (en) Urea derivatives for use in the treatment of fat metabolism disorders.
DE3686483D1 (en) DRUG.
DE69327432D1 (en) MEDICINE FOR Wounds and Hemorrhoid
AU1923088A (en) Piperazinyl derivatives of purines and isosteres thereof as hypoglycemic agents
PT86186A (en) Process for the preparation of benzimidazol derivatives and of pharmaceutical compositions containing the same
RU93032613A (en) PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF PATIENTS WITH PROLONGED COAGULATION TIME, METHOD OF TREATING PATIENTS, USING THE EPI INHIBITOR FOR OBTAINING THE PHARMACEUTICAL PREPARATION
ES2088959T3 (en) 11-BETA-ARIL-4-PREMIERE, PROCEDURE FOR ITS PREPARATION AND APPLICATION AS A MEDICINAL PRODUCT.
AU625402B2 (en) Transdermal system exhibiting graduated drug release and its use for the local or systemic administration of active substances
BE890808A (en) NOVEL GALENIC FORM OF ADMINISTRATION OF METOCLOPRAMIDE, ITS PREPARATION METHOD AND MEDICINAL PRODUCT COMPRISING THIS NOVEL FORM
KR970032872A (en) Drugs for the treatment of skin damage containing acetylsalicylic acid
AU1950388A (en) Pharmaceutical formulation ensuring the transdermal absorption of the active ingredient and process for preparing same
JPS5218813A (en) Plasters for the relief of cutaneous diseases
US4117120A (en) Medication for herpes simplex and canker sores
NL7705855A (en) PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE SUBSTITUATED BENZAMIDES AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS.
IE45282L (en) Pharmaceutical tablet formulation
IL52792A (en) 5-substituted-4-amino-thiophene-3-carboxylic acid derivatives,their preparation and antiobesity and blood lipid lowering pharmaceutical compositions containing them
GB2021409A (en) Pharmaceutical composition
DE3874390D1 (en) CARBOXYSTYRENE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING IT AS AN ACTIVE SUBSTANCE.
EP0310126A3 (en) Derivatives of pyrocatechol-carboxylic acid, their preparation and use as active ingredients in medicines
IE831551L (en) Eye ointment.
CY1228A (en) Bronchospasmolytically active compounds,processes for their preparation,pharmaceutical preparations containing them and their medicinal use
MY114218A (en) The use of bambuterol or a pharmaceutically acceptable salt thereof, to make lipid lowering pharmaceutical preparations.
JPS6485914A (en) Use of n-(2-(diethylamino)ethyl)-2-methoxy-4- ((1-h-4,5-dihydro-2-imidazolyl)amino)-5- chlorobenzamide as antianxiety and antipsychotic
JPS6442437A (en) Antiviral external drug and manufacture